Recall Register

Drug recall: MONISTAT 1 SIMPLE CURE (Miconazole Nitrate Vaginal Insert) 1200 mg ovule, 1-DAY MAXIMUM STRENGTH TREATMENT OVULE per…

Class III FDA enforcement event 70932. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Marketed without an approved NDA/ANDA: The distributed units of Monistat 1 Simple Cure include only the 1200 mg vaginal suppository; the approved NDA requires both a 1200 mg vaginal suppository and the 2% topical cream.

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Medtech Products, Inc. started this drug recall on 10 Apr 2015. The firm address in the FDA record is in Tarrytown, NY. FDA put the recall in Class III. FDA event 70932 has 1 product record. The first FDA enforcement report date is 20 May 2015. The record gives the status Terminated, with the termination date 3 Mar 2016.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide

Recalling firm

Medtech Products, Inc., Tarrytown, NY.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 70932: product records
Recall numberProductQuantityClassStatusReport date
D-1077-2015MONISTAT 1 SIMPLE CURE (Miconazole Nitrate Vaginal Insert) 1200 mg ovule, 1-DAY MAXIMUM STRENGTH TREATMENT OVULE per case, over-the-counter, Distributed by INSIGHT Pharmaceuticals, LLC, Trevose, PA 19053-8433, NDC 63736-013-304,175 cases (50,100 ovules); and 6 cases (72 ovules) as company samplesClass IIITerminated20 May 2015

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2015
292
Share of these events in Class III
31%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
5

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 70932. https://recallregister.com/fda/iii/70932/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide
What quantity of product is in FDA event 70932?
The FDA record gives this quantity: 4,175 cases (50,100 ovules); and 6 cases (72 ovules) as company samples
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2015 have the same class?
31% of the 292 drug events that started in 2015 are in Class III.